Comorbidities and predictors of health-related quality of life in Dravet syndrome: a ten-year prospective follow- up study.

This 10-year prospective follow-up study highlights the significant HRQOL-associated cognitive, social and physical decline particularly affecting younger patients with DS. Sodium channel blocker use appears to negatively impact long-term HRQOL highlighting the importance of early diagnosis and disease specific management in DS.